Our Pricing

Understanding Mounjaro Price and Value in the UK Market

Published on: June 03, 2026

When evaluating mounjaro price options across UK pharmacies, transparency and clinical quality matter as much as cost. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in adults with a BMI of 30 or above, or 27 with weight-related comorbidities[1]. At Cured Pharmacy, we provide upfront pricing at £124.99 per treatment pack, with an additional £20 discount available using code Weightlossnew, ensuring you receive genuine UK-licensed medication following a comprehensive clinical assessment by our registered prescribers.

What Determines Mounjaro Price Across UK Pharmacies

The mounjaro price you encounter varies significantly across UK registered pharmacies due to several factors including supply chain arrangements, consultation fees, dispensing costs, and pharmacy margins. Unlike over-the-counter medications, Mounjaro is a prescription-only medicine requiring clinical oversight, which means the total cost includes both the medication itself and the professional services surrounding its safe supply[2].

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) has structured our pricing model to eliminate hidden fees. The £124.99 price includes your medication, clinical consultation with a UK-registered prescriber, and dispensing services. We've built relationships with licensed wholesalers to secure competitive pricing without compromising on the authenticity or quality of the medication supplied.

Some pharmacies advertise lower headline prices but add consultation fees, delivery charges, or subscription commitments that inflate the actual cost. Our transparent approach means the price you see is the price you pay, with the only additional saving available through our Weightlossnew discount code offering £20 off your first order. This brings your initial treatment cost to £124.99, representing genuine value in the UK market.

Mounjaro Price Comparison: Dosage Strengths and Treatment Phases

Understanding mounjaro price requires knowledge of the dosing schedule, as treatment follows a structured titration protocol. Mounjaro is available in six dosage strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. The MHRA-approved dosing schedule begins with 2.5mg once weekly for four weeks, then increases to 5mg for four weeks, with further escalation based on individual response and tolerability[1].

Each Mounjaro pack contains four pre-filled KwikPen injectors, providing a four-week supply regardless of strength. This means your monthly mounjaro price remains consistent at £124.99 throughout your treatment journey, whether you're on the initial 2.5mg dose or the maintenance 15mg dose. This pricing structure differs from some weight management medications where higher strengths command premium prices.

Clinical trials, including the SURMOUNT-1 study, demonstrated that participants achieved an average weight reduction of 15-20% of body weight over 72 weeks when following the complete titration protocol[3]. The consistency in pricing across dosage strengths removes financial barriers to optimal dose escalation, allowing prescribers to focus purely on clinical appropriateness rather than cost considerations when determining your treatment pathway.

Starter Versus Maintenance Mounjaro Price Considerations

Many patients question whether the mounjaro price differs between starter and maintenance phases. At Cured Pharmacy, we maintain uniform pricing throughout your treatment journey. The starter doses (2.5mg and 5mg) are not discounted, nor are the higher maintenance doses (10mg, 12.5mg, 15mg) subject to price increases. This approach supports treatment adherence by eliminating financial uncertainty as you progress through the titration schedule recommended by your prescriber.

How Mounjaro Price Reflects Clinical Value and Efficacy

When assessing mounjaro price, it's essential to consider the clinical outcomes demonstrated in robust trial data. The SURMOUNT clinical trial programme enrolled over 5,000 participants and showed that tirzepatide delivered superior weight loss compared to placebo, with participants losing an average of 15-22.5% of their baseline body weight depending on the dose achieved[3].

This level of efficacy, combined with improvements in cardiometabolic markers including HbA1c, blood pressure, and lipid profiles, positions Mounjaro as a clinically significant intervention rather than a cosmetic product. The medication works through dual agonism of GIP and GLP-1 receptors, enhancing insulin secretion, reducing glucagon, slowing gastric emptying, and promoting satiety through central appetite regulation[4].

From a health economics perspective, the mounjaro price must be weighed against potential reductions in obesity-related healthcare costs, including management of type 2 diabetes, cardiovascular disease, sleep apnoea, and osteoarthritis. While the upfront monthly cost is £124.99, many patients find this represents value when considered alongside the comprehensive metabolic benefits and the potential to reduce or discontinue other weight-related medications under medical supervision.

Mounjaro Price and Prescription Requirements in the UK

The mounjaro price you pay includes mandatory clinical assessment because tirzepatide is a prescription-only medicine under UK law. The Medicines and Healthcare products Regulatory Agency (MHRA) classification reflects the medication's potency and the need for professional oversight to ensure safe, appropriate use. At Cured Pharmacy, every Mounjaro request undergoes review by a UK-registered prescriber who evaluates your medical history, current medications, and suitability criteria[5].

Our online consultation takes under three minutes to complete and covers essential safety screening including contraindications such as personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and previous pancreatitis. The prescriber also assesses your BMI, weight loss goals, previous weight management attempts, and any coexisting conditions that may influence treatment decisions.

This clinical governance is built into the £124.99 mounjaro price and represents a critical safety measure rather than an administrative burden. Prescribers may determine that alternative treatments such as Wegovy (semaglutide), Saxenda (liraglutide), or Orlistat are more appropriate based on your individual clinical profile, medical history, or treatment goals. This personalised approach ensures you receive the most suitable intervention rather than simply the medication you initially enquired about.

What's Included in Your Mounjaro Price at Cured Pharmacy

The £124.99 mounjaro price at Cured Pharmacy includes your four-week medication supply, full clinical consultation with a UK-registered prescriber, dispensing by our GPhC-registered pharmacy team, discreet packaging, and next-day delivery across the UK. There are no hidden subscription fees, no automatic renewals without your consent, and no additional consultation charges for ongoing prescriptions. Using code Weightlossnew reduces your first order to £124.99, providing genuine savings on an already competitive price point.

Mounjaro Price Versus Alternative Weight Loss Treatments

When comparing mounjaro price against other licensed weight management medications, it's important to evaluate both cost and clinical efficacy. Wegovy (semaglutide), another GLP-1 receptor agonist, is priced from £124.99 at Cured Pharmacy and demonstrated average weight loss of 15% in the STEP trial programme[6]. Saxenda (liraglutide), a daily injection, starts from £124.99 and achieved approximately 8% weight loss in clinical trials[7].

Mounjaro's dual receptor mechanism targeting both GIP and GLP-1 pathways theoretically offers enhanced metabolic effects compared to GLP-1 agonists alone, which is reflected in the SURMOUNT trial data showing superior weight loss outcomes[3]. However, individual response varies considerably, and some patients achieve excellent results with semaglutide or liraglutide at lower monthly costs. The choice between these agents should be guided by clinical factors including tolerability, injection frequency preference, previous treatment response, and budget considerations.

Oral medications like Orlistat (from £124.99) and Xenical (from £124.99) work through fat absorption inhibition rather than hormonal pathways and typically produce more modest weight loss of 5-10%[8]. These represent more affordable options for patients seeking pharmacological support alongside diet and exercise modifications. The mounjaro price reflects its position as a premium, highly effective intervention within a spectrum of licensed weight management options, each with distinct mechanisms, efficacy profiles, and cost considerations.

Maximising Value: Mounjaro Price Discounts and Long-Term Costs

Beyond the base mounjaro price of £124.99, patients can access additional savings through our Weightlossnew discount code, which provides £20 off the first order, reducing the initial cost to £124.99. This discount applies automatically at checkout when the code is entered, with no minimum purchase requirements or subscription commitments attached.

For long-term treatment planning, it's worth noting that Mounjaro is typically prescribed for sustained periods rather than short-term use. The SURMOUNT trials followed participants for 72 weeks, and clinical guidelines suggest ongoing treatment for weight maintenance once target weight is achieved[3]. At £124.99 per month, this represents an annual investment of £124.99, though many patients find they can transition to lower maintenance doses or alternative agents once significant weight loss is achieved, under prescriber guidance.

We maintain transparent pricing with no automatic price increases mid-treatment, and patients can pause or discontinue at any time without penalty fees. Our superintendent pharmacist Tarun Kumar regularly reviews our pricing structure against market conditions to ensure we offer the most competitive mounjaro price without compromising on medication authenticity, clinical standards, or patient support. All medications supplied are sourced through licensed UK wholesalers and carry full MHRA marketing authorisation, ensuring you receive genuine tirzepatide manufactured to pharmaceutical standards.

Insurance and NHS Availability Affecting Mounjaro Price

Currently, Mounjaro for weight management is not routinely available through NHS prescription in most areas, meaning patients typically access treatment through private prescription at the mounjaro price of £124.99 per month. Some private health insurance policies may provide coverage for obesity medications when prescribed for specific medical indications, though this varies by insurer and policy terms. Patients are advised to check their individual policy documents or contact their insurer directly to determine eligibility for reimbursement of weight management medications prescribed following clinical assessment.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 13 August 2026]
2. General Pharmaceutical Council. (2023). Standards for registered pharmacies. GPhC Professional Standards. [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-218. [accessed 13 August 2026]
4. Frias, J. P., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management. NICE Clinical Guideline CG189. [accessed 13 August 2026]
6. Wilding, J. P., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 13 August 2026]
7. Pi-Sunyer, X., et al. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 13 August 2026]
8. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care, 27(1), 155-161. [accessed 13 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.